Covestor LTD Supernus Pharmaceuticals, Inc. Transaction History

Covestor LTD

$181 Million
Q3 2025

A detailed history of Covestor LTD transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Covestor LTD holds 2,309 shares of SUPN stock, worth $103,905. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,309

Previous 1,782 29.57%

Holding current value

$103,905

Previous $56,000 96.43%

% of portfolio

0.06%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$31.45 - $47.79 $16,574 - $25,185	527 Added 29.57%	2,309 $110,000
Q2 2025 Aug 11, 2025	BUY	$30.29 - $33.43 $24,171 - $26,677	798 Added 81.1%	1,782 $56,000
Q1 2025 May 12, 2025	SELL	$31.17 - $40.0 $16,488 - $21,160	-529 Reduced 34.96%	984 $32,000
Q4 2024 Feb 13, 2025	SELL	$31.89 - $37.83 $4,400 - $5,220	-138 Reduced 8.36%	1,513 $55,000
Q3 2024 Nov 01, 2024	SELL	$25.77 - $35.16 $154 - $210	-6 Reduced 0.36%	1,651 $51,000

Q2 2024 Aug 09, 2024	SELL	$25.99 - $33.85 $27,159 - $35,373	-1,045 Reduced 38.68%	1,657 $44,000
Q1 2024 May 10, 2024	BUY	$27.11 - $35.17 $9,705 - $12,590	358 Added 15.27%	2,702 $92,000
Q4 2023 Feb 09, 2024	SELL	$22.72 - $29.68 $136 - $178	-6 Reduced 0.26%	2,344 $68,000
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $34,655 - $41,367	1,257 Added 115.0%	2,350 $65,000
Q2 2023 Aug 11, 2023	BUY	$29.91 - $38.73 $6,879 - $8,907	230 Added 26.65%	1,093 $33,000
Q1 2023 May 15, 2023	BUY	$34.93 - $42.03 $29,969 - $36,061	858 Added 17160.0%	863 $31,000
Q4 2022 Feb 13, 2023	SELL	$31.09 - $37.88 $3,202 - $3,901	-103 Reduced 95.37%	5 $0
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $2,850 - $3,505	99 Added 1100.0%	108 $4,000
Q2 2022 Aug 10, 2022	SELL	$25.33 - $34.25 $4,255 - $5,754	-168 Reduced 94.92%	9 $0
Q1 2022 May 13, 2022	BUY	$28.51 - $32.9 $712 - $822	25 Added 16.45%	177 $6,000
Q4 2021 Feb 10, 2022	BUY	$26.37 - $34.22 $4,008 - $5,201	152 New	152 $4,000

Others Institutions Holding SUPN

# of Institutions

330

Shares Held

60.2M

Call Options Held

234K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.41B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account